{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:21:06Z","timestamp":1778664066250,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Grants from National Key Research and Development Program of China","award":["2021YFC2301503"],"award-info":[{"award-number":["2021YFC2301503"]}]},{"name":"Grants from National Key Research and Development Program of China","award":["2022YFC2302900"],"award-info":[{"award-number":["2022YFC2302900"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural and Science Foundation of China","doi-asserted-by":"crossref","award":["82171739"],"award-info":[{"award-number":["82171739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural and Science Foundation of China","doi-asserted-by":"crossref","award":["82171815"],"award-info":[{"award-number":["82171815"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Hygiene and Health Outstanding Leader Project","award":["2022XD060"],"award-info":[{"award-number":["2022XD060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s15010-024-02454-z","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T10:26:33Z","timestamp":1742207193000},"page":"1167-1178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The blood biomarker combination IL-8\/IL-33 and IL-18\/IL-33 distinguish between active tuberculosis and latent infection"],"prefix":"10.1007","volume":"53","author":[{"given":"Huimin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Lowrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-3559","authenticated-orcid":false,"given":"Xiao-Yong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"2454_CR1","unstructured":"WHO. TB Report 2023. Genava; 2023."},{"key":"2454_CR2","doi-asserted-by":"crossref","unstructured":"Chin KL et al. Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Trop Med Infect Dis, 2023. 8(2).","DOI":"10.3390\/tropicalmed8020089"},{"issue":"9979","key":"2454_CR3","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, et al. WHO\u2019s new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet"},{"key":"2454_CR4","doi-asserted-by":"crossref","unstructured":"Rojano B, Caminero JA, Hayek M. Curving Tuberculosis: Current Trends and Future Needs. Ann Glob Health, 2019. 85(1).","DOI":"10.5334\/aogh.2415"},{"issue":"17","key":"2454_CR5","doi-asserted-by":"publisher","first-page":"9710","DOI":"10.1128\/JVI.77.17.9710-9715.2003","volume":"77","author":"A Takeda","year":"2003","unstructured":"Takeda A, et al. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J Virol. 2003;77(17):9710\u20135.","journal-title":"J Virol"},{"issue":"4","key":"2454_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jinf.2018.10.017","volume":"78","author":"J Luo","year":"2019","unstructured":"Luo J, et al. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection. J Infect. 2019;78(4):281\u201391.","journal-title":"J Infect"},{"key":"2454_CR7","doi-asserted-by":"publisher","unstructured":"Jonas DE, Riley SR, Lee LC, Coffey CP, Wang SH, Asher GN, et al. Screening for latent tuberculosis infection in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2023;329(17):1495\u2013509. https:\/\/doi.org\/10.1001\/jama.2023.3954.","DOI":"10.1001\/jama.2023.3954"},{"key":"2454_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1749-6632.2012.06802.x","volume":"1283","author":"J Weiner","year":"2013","unstructured":"Weiner J, Maertzdorf J, Kaufmann SH. The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis. Ann N Y Acad Sci. 2013;1283:22\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"2454_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2334-3-3","volume":"3","author":"MK Sharma","year":"2003","unstructured":"Sharma MK, et al. Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses. BMC Infect Dis. 2003;3:3.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2454_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.tube.2007.12.002","volume":"88","author":"M Thom","year":"2008","unstructured":"Thom M, et al. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection. Tuberculosis (Edinb). 2008;88(4):324\u201334.","journal-title":"Tuberculosis (Edinb)"},{"issue":"5","key":"2454_CR11","doi-asserted-by":"publisher","first-page":"e0267729","DOI":"10.1371\/journal.pone.0267729","volume":"17","author":"RA Bender Ignacio","year":"2022","unstructured":"Bender Ignacio RA, et al. Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition. PLoS ONE. 2022;17(5):e0267729.","journal-title":"PLoS ONE"},{"issue":"11","key":"2454_CR12","doi-asserted-by":"publisher","first-page":"e43438","DOI":"10.1371\/journal.pone.0043438","volume":"7","author":"E Borgstr\u00f6m","year":"2012","unstructured":"Borgstr\u00f6m E, et al. Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker. PLoS ONE. 2012;7(11):e43438.","journal-title":"PLoS ONE"},{"key":"2454_CR13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fimmu.2017.01059","volume":"8","author":"A Dreesman","year":"2017","unstructured":"Dreesman A, et al. Age-Stratified T Cell Responses in Children Infected with Mycobacterium tuberculosis. Front Immunol. 2017;8:1059.","journal-title":"Front Immunol"},{"issue":"2","key":"2454_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1365-3083.2003.01200.x","volume":"57","author":"AC Cubillas-Tejeda","year":"2003","unstructured":"Cubillas-Tejeda AC, et al. Cytokine production and expression of leucocyte-differentiation antigens by human mononuclear cells in response to mycobacterium tuberculosis antigens. Scand J Immunol. 2003;57(2):115\u201324.","journal-title":"Scand J Immunol"},{"issue":"6","key":"2454_CR15","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jinf.2020.09.032","volume":"81","author":"EL Sudbury","year":"2020","unstructured":"Sudbury EL, et al. Mycobacterium tuberculosis-specific cytokine biomarkers to differentiate active TB and LTBI: A systematic review. J Infect. 2020;81(6):873\u201381.","journal-title":"J Infect"},{"key":"2454_CR16","doi-asserted-by":"crossref","unstructured":"Ramos-Espinosa O et al. Gene therapy based in antimicrobial peptides and proinflammatory cytokine prevents reactivation of experimental latent tuberculosis. Pathog Dis, 2016. 74(7).","DOI":"10.1093\/femspd\/ftw075"},{"issue":"4","key":"2454_CR17","doi-asserted-by":"publisher","first-page":"e0152483","DOI":"10.1371\/journal.pone.0152483","volume":"11","author":"M Suzukawa","year":"2016","unstructured":"Suzukawa M, et al. Combined Analysis of IFN-\u03b3, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection. PLoS ONE. 2016;11(4):e0152483.","journal-title":"PLoS ONE"},{"key":"2454_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tube.2016.06.001","volume":"102","author":"J Wu","year":"2017","unstructured":"Wu J, et al. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection. Tuberculosis (Edinb). 2017;102:68\u201375.","journal-title":"Tuberculosis (Edinb)"},{"key":"2454_CR19","doi-asserted-by":"publisher","first-page":"725447","DOI":"10.3389\/fimmu.2021.725447","volume":"12","author":"EM Delemarre","year":"2021","unstructured":"Delemarre EM, et al. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol. 2021;12:725447.","journal-title":"Front Immunol"},{"issue":"12","key":"2454_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/qjmed\/hcad214","volume":"116","author":"H Li","year":"2023","unstructured":"Li H, et al. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. QJM. 2023;116(12):1002\u20139.","journal-title":"QJM"},{"key":"2454_CR21","unstructured":"WHO. Global TB report 2023. Geneva; 2023."},{"key":"2454_CR22","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee, in Guidelines on the Management of Latent Tuberculosis Infection. 2015, World Health Organization Copyright \u00a9 World Health Organization 2015.: Geneva."},{"issue":"5","key":"2454_CR23","doi-asserted-by":"publisher","first-page":"ofaa126","DOI":"10.1093\/ofid\/ofaa126","volume":"7","author":"K Fujita","year":"2020","unstructured":"Fujita K, et al. Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Open Forum Infect Dis. 2020;7(5):ofaa126.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"2454_CR24","first-page":"205521731987546","volume":"5","author":"LE Baldassari","year":"2019","unstructured":"Baldassari LE, et al. Tuberculosis screening in multiple sclerosis: effect of disease-modifying therapies and lymphopenia on the prevalence of indeterminate TB screening results in the clinical setting. Mult Scler J Exp Transl Clin. 2019;5(3):2055217319875467.","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"12","key":"2454_CR25","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s10096-014-2190-z","volume":"33","author":"S Mamishi","year":"2014","unstructured":"Mamishi S, et al. Diagnostic accuracy of IL-2 for the diagnosis of latent tuberculosis: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2014;33(12):2111\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2454_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","volume":"111","author":"L Petrone","year":"2018","unstructured":"Petrone L, et al. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Tuberculosis (Edinb). 2018;111:147\u201353.","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"2454_CR27","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1186\/s12879-019-4466-5","volume":"19","author":"X Qiu","year":"2019","unstructured":"Qiu X, et al. Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis. BMC Infect Dis. 2019;19(1):924.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2454_CR28","doi-asserted-by":"publisher","first-page":"e9051","DOI":"10.1371\/journal.pone.0009051","volume":"5","author":"SA Kabeer","year":"2010","unstructured":"Kabeer SA. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS ONE. 2010;5(2):e9051.","journal-title":"PLoS ONE"},{"issue":"2","key":"2454_CR29","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.advms.2019.09.001","volume":"64","author":"B Pourakbari","year":"2019","unstructured":"Pourakbari B, et al. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-\u03b3 release assays: A systematic review and meta-analysis. Adv Med Sci. 2019;64(2):437\u201343.","journal-title":"Adv Med Sci"},{"key":"2454_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijid.2019.12.012","volume":"91","author":"C Della Bella","year":"2020","unstructured":"Della Bella C, et al. LIOFeron\u00aeTB\/LTBI: A novel and reliable test for LTBI and tuberculosis. Int J Infect Dis. 2020;91:177\u201381.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"2454_CR31","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/ciz034","volume":"69","author":"E Nemes","year":"2019","unstructured":"Nemes E, et al. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube. Clin Infect Dis. 2019;69(10):1724\u201330.","journal-title":"Clin Infect Dis"},{"key":"2454_CR32","doi-asserted-by":"crossref","unstructured":"K J, et al. Association of IL4RA and IL-8 polymorphism in predicting susceptibility towards tuberculosis. Monaldi Arch Chest Dis; 2023.","DOI":"10.4081\/monaldi.2023.2594"},{"issue":"5","key":"2454_CR33","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00430-014-0382-x","volume":"204","author":"M Prabhavathi","year":"2015","unstructured":"Prabhavathi M, et al. Role of QuantiFERON-TB Gold antigen-specific IL-1\u03b2 in diagnosis of active tuberculosis. Med Microbiol Immunol. 2015;204(5):567\u201374.","journal-title":"Med Microbiol Immunol"},{"issue":"4","key":"2454_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jinf.2018.08.010","volume":"78","author":"H Xin","year":"2019","unstructured":"Xin H, et al. Serum level of IL-8 is associated with reversion of QuantiFERON-TB gold in-tube tests. J Infect. 2019;78(4):292\u20138.","journal-title":"J Infect"},{"issue":"3","key":"2454_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2008.02.005","volume":"28","author":"JP Ting","year":"2008","unstructured":"Ting JP, et al. The NLR gene family: a standard nomenclature. Immunity. 2008;28(3):285\u20137.","journal-title":"Immunity"},{"issue":"1","key":"2454_CR36","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1186\/s12879-021-06575-w","volume":"21","author":"J Fenhua","year":"2021","unstructured":"Fenhua J, et al. Diagnostic value of combined pleural interleukin-33, adenosine deaminase and peripheral blood tuberculosis T cell spot detection TB for tuberculous pleurisy. BMC Infect Dis. 2021;21(1):861.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"2454_CR37","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.21037\/apm-21-2582","volume":"10","author":"B Zhang","year":"2021","unstructured":"Zhang B, et al. Association between IL-18, IFN-\u03b3 and TB susceptibility: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(10):10878\u201386.","journal-title":"Ann Palliat Med"},{"key":"2454_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cyto.2016.10.013","volume":"90","author":"GR Kathamuthu","year":"2017","unstructured":"Kathamuthu GR, et al. Reduced systemic and mycobacterial antigen-stimulated concentrations of IL-1\u03b2 and IL-18 in tuberculous lymphadenitis. Cytokine. 2017;90:66\u201372.","journal-title":"Cytokine"},{"key":"2454_CR39","doi-asserted-by":"crossref","unstructured":"Kathamuthu GR et al. Tuberculous Lymphadenitis Is Associated with Enhanced Baseline and Antigen-Specific Induction of Type 1 and Type 17 Cytokines and Reduced Interleukin-1\u03b2 (IL-1\u03b2) and IL-18 at the Site of Infection. Clin Vaccine Immunol, 2017. 24(5).","DOI":"10.1128\/CVI.00045-17"},{"key":"2454_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tube.2015.12.007","volume":"97","author":"T Chen","year":"2016","unstructured":"Chen T, et al. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array. Tuberculosis (Edinb). 2016;97:108\u201317.","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"2454_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cyto.2010.04.005","volume":"51","author":"R Reljic","year":"2010","unstructured":"Reljic R, et al. Cytokine interactions that determine the outcome of Mycobacterial infection of macrophages. Cytokine. 2010;51(1):42\u20136.","journal-title":"Cytokine"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02454-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02454-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02454-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:54:23Z","timestamp":1749016463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02454-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2454"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02454-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"14 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Shanghai Public Health Clinical Center, and informed consent was obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}